Subject(s)
Biliary Tract/parasitology , Echinococcosis, Hepatic/diagnosis , Echinococcosis, Hepatic/surgery , Pancreatitis/surgery , Sphincterotomy, Endoscopic/methods , Acute Disease , Adult , Aged , Aged, 80 and over , Cholangiopancreatography, Endoscopic Retrograde , Echinococcosis, Hepatic/complications , Female , Follow-Up Studies , Humans , Male , Pancreatitis/etiology , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
We describe a 60-year-old man with idiopathic portal hypertension and hepatic angiosarcoma. The patient had taken an arsenical preparation for the treatment of psoriasis for 10 years. Five cases of this association have been reported previously; in one only, exposure to arsenical salts was present.
Subject(s)
Arsenicals/adverse effects , Hemangiosarcoma/chemically induced , Hypertension, Portal/chemically induced , Liver Neoplasms/chemically induced , Arsenicals/therapeutic use , Humans , Male , Middle Aged , Psoriasis/drug therapyABSTRACT
OBJECTIVE: Different studies have demonstrated that factors such as transmission route, disease duration and age at the time of infection can influence the histological evolution of chronic hepatitis by the hepatitis C virus (HCV). The aim of this study was to determine if epidemiological factors such as disease duration and transmission route influence the severity of the histological lesions of patients with chronic hepatitis by HCV. DESIGN: A prospective study. METHODS: The hepatic biopsies of 101 patients diagnosed with chronic hepatitis by HCV were studied. The patients were divided into three groups according to transmission mode: (1) post-transfusional (n = 28), (2) associated with the use of drugs by parenteral route or intravenous drug use (n = 28), and (3) sporadic hepatitis (n = 45). RESULTS: We found more severe forms of hepatopathy in post-transfusional hepatitis and sporadic groups than in the intravenous drug user group of patients. The disease evolution time was significantly higher in patients diagnosed as having chronic active hepatitis with or without cirrhosis (13.8 +/- 9 years) than in patients with chronic persistent hepatitis (8 +/- 4 years), P < 0.01. We found a significant correlation between the evolution time of the infection by HCV and the Histology Activity Index (P < 0.01). The multivariate analysis showed that only the transmission route and the disease evolution time are predictive variables of Histology Activity Index in chronic hepatitis C. CONCLUSION: These results suggest that the post-transfusional and sporadic transmission routes and a greater evolution time of the disease are epidemiological variables that are associated with the presence of more severe histological lesions in chronic hepatitis C.
